Prenuvo key facts
as of Oct 2026- Developer of a whole-body magnetic resonance imaging scan technology designed for precision medicine, bringing quantitative reproducibility to radiology.
- Prenuvo is valued at approximately $600.0M as of Oct 2026, set at its later-stage round, Feb 2025; nothing has traded since, per PrivateMarketView’s mark.
- It has raised $191.8M across 1 recorded rounds; the latest was Later Stage VC ($85.0M) in Jun 2024.
- Notable investors include StartX (US), BDC Capital, Felicis, Caffeinated Capital, Operator Partners — 18 tracked in total.
- Prenuvo has filed 1 Form D with the SEC, most recently Feb 2025 ($85.0M sold to 13 investors).
- Status: Privately Held (backing).
Valued at $600.0M at its later-stage round, Feb 2025. Nothing has traded since.
- ·The complete investor list: 18 names
- ·Watch Prenuvo: the Monday email on marks, rounds and moves
Prenuvo funding rounds
1 roundsWho backs Prenuvo
18+Membership and data by Private Market View
Prenuvo valuation
Prenuvo was valued at $600 million at its later-stage round in Feb 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Prenuvo raised?
Prenuvo has raised $192 million in total; 1 of its rounds is on record. The largest on record was an $85 million later-stage round in Jun 2024.
Prenuvo has filed 1 Form D with the SEC, most recently in Feb 2025 ($85 million sold to 13 investors).
Prenuvo investors
18 investors are on record for Prenuvo, including StartX (US), BDC Capital, Felicis and Caffeinated Capital. By type, the record holds 4 venture capital firms, 1 angel investor and 1 growth equity firm. The later-stage round in Jun 2024 drew 13 investors.
About Prenuvo
Developer of a whole-body magnetic resonance imaging scan technology designed for precision medicine, bringing quantitative reproducibility to radiology. The company's technology offers a range of multiparametric Magnetic resonance imaging techniques for cancer, brain, thoracic, abdomen, liver, reproductive organ, and spine-related diagnostics, enabling patients and pharmaceutical companies to have a clinically accurate and affordable way to detect early symptoms.
- Sector
- Healthcare
- HQ
- Los Angeles, CA, United States
- Founded
- 2018
- Employees
- 186
- Website
- prenuvo.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.